Chemours

The Chemours Co. is a holding company, which engages in the provision of performance chemicals. The firm delivers solutions, which include a range of industrial and chemical products for markets including coatings, plastics, refrigeration and air conditioning, transportation, semiconductor and consumer electronics, and general industrial. It operates through the following segments: Titanium Technologies, Thermal and Specialized Solutions, Advanced Performance Materials, and Chemical Solutions. The Titanium Technologies segment is involved in the manufacture of titanium dioxide pigment. The Thermal and Specialized Solutions segment offers refrigerants, propellants, blowing agents, and specialty solvents. The Advanced Performance Materials segment produces polymers and advanced materials that deliver attributes, including chemical inertness, thermal stability, low friction, weather and corrosion resistance, extreme temperature stability, and di-electric properties. The Chemical Solutions segment refers to the sale of chemicals used in industrial and consumer applications in the Americas. The company was founded on February 18, 2014, and is headquartered in Wilmington, DE.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Chemours overcomes Q4 challenges, eyes growth and sustainability in 2023

Chemours had a tough Q4 but a successful year overall, with a focus on margin improvement, growth in key businesses, and addressing legacy issues. The company is optimistic about 2023, emphasizing sustainability-led growth and returning value to shareholders.

Chemours reports strong Q1 performance, navigates challenges, eyes growth opportunities

Chemours' Q1 2023 Earnings Call highlighted strong performance, reaffirmed guidance, and emphasized margin improvement strategies. The company faces challenges from macroeconomic uncertainties and inflationary pressures but sees opportunities in sustainable initiatives and market-led innovation. Chemours remains confident in its full-year outlook and growth strategies.

Chemours reports record results, eyes cost reduction and innovation

Chemours had a strong quarter with record results and notable achievements in facility closures and settlements. While challenges lie ahead with a weaker second half expected, the company remains focused on shareholder value and strategic priorities. Opportunities in cost reduction, innovation, and market leadership position Chemours for future growth.

Chemours addresses challenges, eyes growth in sustainable solutions market

Chemours Company navigated challenges in Q3 2023, with a focus on long-term shareholder value and strategic transformation for performance improvement.
Strong performance in Performance Solutions and TSS business, alongside cost savings initiatives, position Chemours for future growth and margin recovery.
Management's commitment to driving value for shareholders amidst industry challenges underscores a proactive approach to addressing market dynamics.

Chemours reports Q4 sales growth, addresses TiO2 market challenges

Chemours is navigating challenges in the TiO2 market while focusing on cost reduction and growth opportunities in other segments. The company aims to maintain competitiveness through strategic decisions and investments in R&D. Analysts' inquiries during the earnings call highlighted concerns about leadership stability and various segment dynamics.

Chemours reports mixed Q1 results, eyes sequential growth in 2024

Chemours' Q1 2024 performance reflected mixed results across segments, with a focus on cost efficiencies, transformation plans, and maintaining liquidity amidst declining net sales and EBITDA.
Despite challenges in certain segments and market uncertainties, Chemours remains optimistic about sequential growth in the second quarter, aiming for significant EBITDA potential in 2024 and long-term financial improvement.
Strategic strengths in cost management, growth initiatives, and market opportunities position Chemours to navigate challenges, drive growth, and enhance profitability in a dynamic business environment.

Chemours exceeds volume expectations amidst challenges, anticipates sequential decline

Chemours demonstrated resilience and growth in key product lines despite facing challenges in Q1 and Q2.
The company's cost-saving efforts and recovery in certain segments highlight its ability to adapt to market conditions.
While financial results were impacted by one-time costs and a decline in net sales, Chemours maintained a strong net leverage ratio.
Anticipated sequential decline in net sales for Q3 underscores the need for strategic planning and operational optimization.

Chemours reports strong Q3 performance amidst strategic growth initiatives

Chemours' Q3 performance reflects operational strength and growth in key segments.
Challenges include declines in net sales for TSS and TT in Q4 and a net loss.
Opportunities exist in cost savings, growth in Opteon refrigerants, and strategic investments.
Overall, Chemours remains confident in its strategy to drive shareholder value.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

The Chemours Co. is a holding company, which engages in the provision of performance chemicals. The firm delivers solutions, which include a range of industrial and chemical products for markets including coatings, plastics, refrigeration and air conditioning, transportation, semiconductor and consumer electronics, and general industrial. It operates through the following segments: Titanium Technologies, Thermal and Specialized Solutions, Advanced Performance Materials, and Other. The Titanium Technologies segment is involved in the manufacture of titanium dioxide pigment. The Thermal and Specialized Solutions segment offers refrigerants, propellants, blowing agents, and specialty solvents. The Advanced Performance Materials segment produces polymers and advanced materials that deliver attributes, including chemical inertness, thermal stability, low friction, weather and corrosion resistance, extreme temperature stability, and di-electric properties. The Other segment consists of performance chemicals and intermediates business. The company was founded on February 18, 2014, and is headquartered in Wilmington, DE.

Chemours Company has underperformed the Russell 2000 and other material stocks in 2024, with negative returns of 36% on a YTD basis. Even though the current quarter is unlikely to be the greatest on account of seasonal issues, we are choosing to be cautiously optimistic on CC now. CC's most profitable division by far -Thermal & Specialized Solutions, is driving topline growth again, as regulatory tailwinds abet the Opteon portfolio.

Chemours: Hasn't Been A Great Year, But The Long-Term Prospects Look Bright

WILMINGTON, Del.--(BUSINESS WIRE)---- $CC--The Chemours Company Announces Pricing of Private Offering of $600,000,000 of 8.000% Senior Notes Due 2033.

The Chemours Company Announces Pricing of Private Offering of $600,000,000 of 8.000% Senior Notes Due 2033

WILMINGTON, Del.--(BUSINESS WIRE)---- $CC--The Chemours Company Announces Private Offering of $600,000,000 of Senior Notes Due 2033.

The Chemours Company Announces Private Offering of $600,000,000 of Senior Notes Due 2033

Dow Inc

Mercer International

During times of turbulence and uncertainty in the markets, many investors turn to dividend-yielding stocks. These are often companies that have high free cash flows and reward shareholders with a high dividend payout.

Wall Street's Most Accurate Analysts Weigh In On 3 Materials Stocks With Over 4% Dividend Yields

CC sees record Q3 sales in the Thermal & Specialized Solutions division, driven by the growth in Opteon refrigerants.

Chemours' Earnings and Revenues Surpass Estimates in Q3

The Chemours Company (NYSE:CC ) Q3 2024 Earnings Call Transcript November 4, 2024 8:00 AM ET Company Participants Brandon Ontjes - VP of IR Denise Dignam - President and CEO Shane Hostetter - CFO Conference Call Participants Arun Viswanathan - RBC Capital Markets Josh Spector - UBS Mike Leithead - Barclays Vincent Andrews - Morgan Stanley Laurence Alexander - Jefferies John Roberts - Mizuho Hassan Ahmed - Alembic Global Advisors John McNulty - BMO Operator Good morning. My name is Daniel and I will be your conference operator today.

The Chemours Company (CC) Q3 2024 Earnings Call Transcript

The headline numbers for Chemours (CC) give insight into how the company performed in the quarter ended September 2024, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.

Chemours (CC) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates

Chemours (CC) came out with quarterly earnings of $0.40 per share, beating the Zacks Consensus Estimate of $0.32 per share. This compares to earnings of $0.64 per share a year ago.

Chemours (CC) Q3 Earnings and Revenues Top Estimates

WILMINGTON, Del.--(BUSINESS WIRE)---- $CC--The Chemours Company Reports Third Quarter 2024 Results and Outlines Refreshed Corporate Strategy.

The Chemours Company Reports Third Quarter 2024 Results and Outlines Refreshed Corporate Strategy

Chemours (CC) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Earnings Preview: Chemours (CC) Q3 Earnings Expected to Decline

Huntsman

Wall Street's Most Accurate Analysts Spotlight On 3 Materials Stocks Delivering High-Dividend Yields

WILMINGTON, Del.--(BUSINESS WIRE)---- $CC--Chemours Announces Fourth Quarter Dividend.

Chemours Announces Fourth Quarter Dividend

Apollo Global Management

Celsius Holdings

Cleveland-Cliffs

Dollar General

Dollar Tree

Five Below

Wolfspeed rallied due to a $750 million investment from Apollo Global Management, despite high short interest and bearish sentiment. SolarEdge Technologies faces significant competition and high inventory levels, making it a potential tax-loss selling candidate. Moderna's stock is under pressure due to declining Covid-19 vaccine demand and weakened profitability, suggesting it should be sold.

Top 7 Tax-Loss Stocks To Sell By October 31, 2024

WILMINGTON, Del.--(BUSINESS WIRE)---- $CC--Chemours Announces Dates for Third Quarter 2024 Earnings Release and Webcast Conference Call.

Chemours Announces Dates for Third Quarter 2024 Earnings Release and Webcast Conference Call

Wall Street's Most Accurate Analysts Give Their Take On 3 Materials Stocks With Over 4% Dividend Yields

NEW YORK, NY / ACCESSWIRE / September 13, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of The Chemours Company ("The Chemours Company") (NYSE:CC) concerning possible violations of federal securities laws. Chemours issued a press release on August 1, 2024, reporting its financial results for the second quarter of 2024.

ATTENTION The Chemours Company Investors: You May Have Been Affected by Fraud - Contact Levi & Korsinsky to Discuss Your Rights

NEW YORK, NY / ACCESSWIRE / September 12, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of The Chemours Company ("The Chemours Company") (NYSE:CC) concerning possible violations of federal securities laws. Chemours issued a press release on August 1, 2024, reporting its financial results for the second quarter of 2024.

The Chemours Company Investigation Ongoing: Contact Levi & Korsinsky to Discuss Your Rights - CC

Tronox

Wall Street's Most Accurate Analysts Give Their Take On 3 Materials Stocks Delivering High-Dividend Yields

NEW YORK, NY / ACCESSWIRE / September 11, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of The Chemours Company ("The Chemours Company") (NYSE:CC) concerning possible violations of federal securities laws. Chemours issued a press release on August 1, 2024, reporting its financial results for the second quarter of 2024.

Lost Money on The Chemours Company(CC)? Contact Levi & Korsinsky Regarding an Ongoing Investigation

CC anticipates its Opteon portfolio to save an estimated 325 million tons of carbon dioxide equivalent by 2025.

Chemours Develops Low GWP Retrofit Approach for Vehicles

NEW YORK, NY / ACCESSWIRE / September 10, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of The Chemours Company ("The Chemours Company") (NYSE:CC) concerning possible violations of federal securities laws. Chemours issued a press release on August 1, 2024, reporting its financial results for the second quarter of 2024.

Levi & Korsinsky Reminds Shareholders of an Investigation into The Chemours Company (CC) Regarding Potential Securities Fraud Allegations

NEW YORK, NY / ACCESSWIRE / September 9, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of The Chemours Company ("The Chemours Company") (NYSE:CC) concerning possible violations of federal securities laws. Chemours issued a press release on August 1, 2024, reporting its financial results for the second quarter of 2024.

Levi & Korsinsky Investigates Possible Securities Fraud Violations by The Chemours Company (CC)

WILMINGTON, Del.--(BUSINESS WIRE)---- $CC--Chemours Announces Development of a Low GWP Retrofit Approach for Vehicles Using the Legacy R-134A Mobile Air Conditioning Refrigerant.

Chemours Announces Development of a Low GWP Retrofit Approach for Vehicles Using the Legacy R-134a Mobile Air Conditioning Refrigerant

NEW YORK, NY / ACCESSWIRE / September 7, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of The Chemours Company ("The Chemours Company") (NYSE:CC) concerning possible violations of federal securities laws. Chemours issued a press release on August 1, 2024, reporting its financial results for the second quarter of 2024.

The Chemours Company Investigated by Shareholder Rights Advocates - Investors Should Contact Levi & Korsinsky Regarding Potential Securities Law Violations - CC

NEW YORK, NY / ACCESSWIRE / September 7, 2024 / Pomerantz LLP is investigating claims on behalf of investors of The Chemours Company ("Chemours" or the "Company") (NYSE:CC). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext.

News for Chemours Stock (CC)